254 related articles for article (PubMed ID: 17322098)
1. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
3. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.
Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H
Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
5. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
6. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
7. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
[TBL] [Abstract][Full Text] [Related]
8. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
9. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
[TBL] [Abstract][Full Text] [Related]
10. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
[TBL] [Abstract][Full Text] [Related]
11. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
13. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
15. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
[TBL] [Abstract][Full Text] [Related]
16. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments.
Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317
[TBL] [Abstract][Full Text] [Related]
17. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
18. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor.
Chiang TM; Jin A; Kang AH
J Immunol; 1987 Aug; 139(3):887-92. PubMed ID: 3598192
[TBL] [Abstract][Full Text] [Related]
19. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
20. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
